GILD
Gilead Sciences Inc.
Latest News for GILD
Shares in biopharmaceutical company Arcus Biosciences ($RCUS) collapsed 17% in pre-market trading after it said it was stopping a late-stage study ......
In a report released yesterday, Mohit Bansal from Wells Fargo maintained a Buy rating on Gilead Sciences, with a price target of $150.00. Bansal co......
In a report released yesterday, Carter Gould from Cantor Fitzgerald maintained a Buy rating on Gilead Sciences, with a price target of $135.00. Gou......
In a report released on November 26, Courtney Breen from Bernstein maintained a Buy rating on Gilead Sciences, with a price target of $135.00. The ......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Regeneron (REGN – Research Report), Gilead Sciences ......
Gilead Sciences ( ($GILD) ) has provided an update. On November 19, 2025, Gilead Sciences announced that Deborah H. Telman will step down from her ......
News data is sourced from MarketXLS API and updated regularly.
Showing 6 of 6 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GILD | $120.40 | -2.3% | 6.77M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |